Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
7 enrolled 14 charts
FAISA-CORPPS
Completed
30 enrolled
Evaluations of Alcohol Warning Labels
Phase NA Completed
1,053 enrolled 15 charts
EARN
Phase NA Completed
33 enrolled
KEYVIBE-005
Phase 2 Completed
613 enrolled
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
ABIMMUNE
Phase 1/2 Completed
54 enrolled
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Completed
58 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
PREFER
Completed
1,429 enrolled
MOM
Completed
40 enrolled
ACTolog
Phase 1 Completed
38 enrolled
A First in Human, Dose Escalation Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors
Phase 1 Completed
38 enrolled
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Phase 1 Completed
48 enrolled
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Phase 1 Completed
184 enrolled 20 charts
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis
Phase 3 Completed
100 enrolled
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
Phase 1/2 Completed
126 enrolled
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Phase 1 Completed
132 enrolled
Radiogenomics in Aerodigestive Tract Cancers
Completed
139 enrolled
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Phase 2 Completed
45 enrolled
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Phase 1/2 Completed
133 enrolled
MORRIS
Completed
118 enrolled
Adaptive Pet Study
Phase NA Completed
271 enrolled
A Study of PRT1419 in Patients With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Phase 1 Completed
17 enrolled 14 charts
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
52 enrolled 25 charts
DETECT
Completed
458 enrolled
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Phase 1 Completed
20 enrolled
First-in-human Study of S-588210 (S-488210+S-488211)
Phase 1 Completed
10 enrolled
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
Phase 1/2 Completed
195 enrolled 51 charts
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Phase 1 Completed
40 enrolled
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.
Phase 2 Completed
5 enrolled 8 charts
DRIHNC - Dehydration Reduction in Head & Neck Cancer
Phase NA Completed
41 enrolled
Investigator Initiated Phase 1 Study of TBI-1201
Phase 1 Completed
18 enrolled
PCA062 in pCAD-positive Tumors.
Phase 1 Completed
47 enrolled
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Phase 1 Completed
22 enrolled
PREMED-F1
Phase 3 Completed
27 enrolled
A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer
Phase NA Completed
44 enrolled 4 charts
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
Phase 1 Completed
16 enrolled
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
Phase 1 Completed
6 enrolled
INFORM
Completed
170 enrolled
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
103 enrolled 14 charts
TRT-001
Phase 1 Completed
93 enrolled
A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer
Phase NA Completed
10 enrolled 7 charts
RAMPART
Phase NA Completed
40 enrolled
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Phase 4 Completed
540 enrolled 25 charts
PETANC
Phase NA Completed
20 enrolled
Bupropion in Helping Adults Stop Smoking
Phase 2 Completed
95 enrolled 8 charts